𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antifungal prophylaxis for severely neutropenic chemotherapy recipients : A meta-analysis of randomized-controlled clinical trials

✍ Scribed by Eric J. Bow; Michel Laverdière; Nathalie Lussier; Coleman Rotstein; Mary S. Cheang; Stratis Ioannou

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
454 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antifungal prophylaxis for severely neut
Antifungal prophylaxis for severely neutropenic chemotherapy recipients : A meta-analysis of randomized-controlled clinical trials
✍ Eric J. Bow; Michel Laverdière; Nathalie Lussier; Coleman Rotstein; Mary S. Chea 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

## Abstract ## BACKGROUND The overall clinical efficacy of the azoles antifungal agents and low‐dose intravenous amphotericin B for antifungal chemoprophylaxis in patients with malignant disease who have severe neutropenia remains unclear. ## METHODS Randomized‐controlled trials of azoles (fluco

How complete is the evidence for thrombo
How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials
✍ Gregory M. Bump; Madhavi Dandu; Samuel R. Kaufman; Kaveh G. Shojania; Scott A. F 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB

## Abstract ## OBJECTIVES: Guidelines recommend pharmacologic prophylaxis for hospitalized medical patients at increased risk of thromboembolism. Despite recommendations, multiple studies demonstrate underutilization. Factors contributing to underutilization include uncertainty that prophylaxis re